Global Neuroendoscopy Market to surpass $ 250 Mn by 2025

January 13, 2020


According to the research report titled ‘Neuroendoscopy Market Size By Product (Rigid Neuroendoscopes {Rigid Fiberscopes, Rigid Videoscopes}, Flexible Neuroendoscopes), By Application (Transnasal Neuroendoscopy, Intraventricular Neuroendoscopy, Transcranial Neuroendoscopy), By Usability (Reusable Neuroendoscopes, Disposable Neuroendoscopes), By Patient (Adult, Pediatric), By End-use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers) Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report LLC, the global neuroendoscopy market is expected to cross USD 250 million by the year 2025.
 

According to the report, growing occurrences of brain tumor in tandem with growing elderly population are major factors driving the neuroendoscopy market growth. Advancements in technology pertaining to minimally invasive methods coupled with increasing utilization of such procedures has enabled surgeons and clinicians to minimize morbidity during surgeries, thereby aiding the expansion of the market. Rising prevalence of tumors such as glioma, craniopharyngioma, meningioma, glioblastoma, astrocytoma, and acoustic neuroma are augmenting the demand for neuroendoscopy treatment procedures across the globe.
 

As per product type, the report cites that rigid neuroendoscopes market segment was worth USD 120 million in the year 2018 and is expected to register continuous growth during the forecast period. Rising adoption of such products in intraventricular neuroendoscopy surgeries are fueling the growth of the segment.
 

Based on the application spectrum, transnasal neuroendoscopy segment is predicted to hold 25.1% share of the overall market by the year 2025. Advancements in surgical instruments has enabled surgeons to conduct complex surgeries through personalized minimally invasive methods, thereby facilitating the business scenario.
 

In terms of usability, the report states that disposable neuroendoscopes market segment is estimated to expand with a CAGR of 5.5% during 2019-2025. Surging adoption of temporary disposable neuroendoscopes for central system and brain surgeries are propelling the growth of this market segment.
 

By patient type, the pediatric patient segment was worth USD 25 million in the year 2018 and is presumed to grow consistently during the estimated timeframe. Rising frequency of brainstem gliomas, ependymomas, and astrocytomas among infants along with high presence of skilled pediatric neurosurgeons are driving the market growth.
 

Speaking of end-use segment, the ASCs (ambulatory surgical centers) market segment accounted for 20% share in neuroendoscopy market in the year 2018. Increasing awareness pertaining to ASC benefits like well-equipped devices, shorter stay, and decreased risk of infections is contributing towards the market growth.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2419664/
 

As per the regional analysis, the report claims that Asia-Pacific neuroendoscopy industry was worth USD 30 million in the year 2018. Growing occurrences of central nervous system and brain cancer along with increasing awareness regarding neuroendoscopy procedures are augmenting the product demand across the region.
 

The prominent companies operating in the neuroendoscopy market are Tonglu WANHE Medical Instrument, HAWK, Schindlerendoskopie technologie GmbH, Karlstorzse & Co. KG, Clarus Medical LLC, adeor Medical AG, B. Braun Melsungen AG, and Ackermann Instrumente GmbH.


Frequently Asked Questions (FAQ) :

According to the report, growing occurrences of brain tumor in tandem with growing elderly population are major factors driving the neuroendoscopy market growth. Advancements in technology pertaining to minimally invasive methods coupled with increasing utilization of such procedures has enabled surgeons and clinicians to minimize morbidity during surgeries, thereby aiding the expansion of the market. Rising prevalence of tumors such as glioma, craniopharyngioma, meningioma, glioblastoma, astrocytoma and acoustic neuroma are augmenting the demand for neuroendoscopy treatment procedures across the globe.
The report cites that rigid neuroendoscopes market segment was worth USD 120 million in the year 2018 and is expected to register continuous growth during the forecast period. Rising adoption of such products in intraventricular neuroendoscopy surgeries are fueling the growth of the segment.
The report claims that Asia-Pacific neuroendoscopy industry was worth USD 30 million in the year 2018. Growing occurrences of central nervous system and brain cancer along with increasing awareness regarding neuroendoscopy procedures are augmenting the product demand across the region.
The prominent companies operating in the neuroendoscopy market are Tonglu WANHE Medical Instrument, HAWK, Schindlerendoskopie technologie GmbH, Karlstorzse & Co. KG, Clarus Medical LLC, adeor Medical AG, B. Braun Melsungen AG and Ackermann Instrumente GmbH.